Stockreport
Kaléo Strengthens Leadership Team to Advance Drug Delivery and Autoinjector Innovation [Yahoo! Finance]
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
Richmond, VA, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Kaléo, a global leader in drug-delivery device technology and auto-injectors, today announced the appointment of Ram Halthore as Vice President, Development. He joins Carrie Siragusa, CPA, who was welcomed last year as Vice President, Marketing and Public Relations, reflecting the Company's continued investment in leadership to support innovation, growth, and preparedness across its portfolio. For 25 years, Kaléo has focused on reimagining how critical medicines are delivered in high-stress, time-sensitive situations. From autoinjector innovation designed to support patients and caregivers during severe allergic emergencies, to development programs supporting preparedness in complex and high-risk environments, the Company's work has centered on reliability, usability, and trust. Advancing Development for Disease Management and Global Health Security In his role as Vice President, Development, Ram Halthore will lead device and drug
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | AMGN | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
AMGN alerts
AMGN alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
NEWS
NEWS
- Nonprofit Health Services Organization Files Lawsuit Against Fortune 500 Pharmaceutical Company Over Prescription Drug Access[Business Wire]
- Amgen (NASDAQ:AMGN) was downgraded by analysts at Sanford C. Bernstein from an "outperform" rating to a "market perform" rating. They now have a $335.00 price target on the stock.[MarketBeat]
- Should You Buy, Sell or Hold J&J Stock Ahead of Q4 Results? [Yahoo! Finance][Yahoo! Finance]
- Is Evotec SE (EVO) One of the Best Debt-Free Penny Stocks to Buy Right Now? [Yahoo! Finance][Yahoo! Finance]
- Amgen Inc. (NASDAQ:AMGN) is largely controlled by institutional shareholders who own 80% of the company [Yahoo! Finance][Yahoo! Finance]
- More
AMGN
SEC Filings
SEC Filings
- 11/21/25 - Form 4
- 11/20/25 - Form 144
- 11/13/25 - Form 4
- AMGN's page on the SEC website
- More